Semaglutide provides sustained appetite reduction that can be maintained for years
With the recent increase in sales, many manufacturers are clamoring to get a piece of the GLP-1 pie"
Regular documentation using standardized measurement protocols enables patients and clinicians to optimize dosing, manage adverse effects, and make informed decisions about treatment continuation
A patient may arrive with fatigue, weight changes, poor sleep, or fertility concerns, but the primary task is to sort out whether the driver is thyroid, ovarian, testicular, adrenal, metabolic, or mixed
GLP-1 RA use was identified as an independent risk factor for food retention (OR 9.19, p = 0.0003)